check_circleStudy Completed

Diabetes Mellitus, Type 1

Bayer Identifier:
Trial_0221
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Effect of acarbose (Bay g 5421) on the insulin consumption of children treated with insulin

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

7 - 15 Years

Trial summary

Enrollment Goal
10
Trial Dates
December 1978 - March 1980
Phase
N/A
Could I Receive a placebo
N/A
Products
Acarbose (Precose/Glucobay, BAYG5421)
Accepts Healthy Volunteer
N/A

Trial design

The effect of acarbose (Bay g 5421) on the insulin consumption of children treated with insulin.
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.